Together with the most sensitive and specific markers, CgA and SYN [18], a novel biomarker, INSM1, has been proposed as an accurate indicator of NE differentiation of BC to support NEN diagnosis [5, 19, 20]. The gene discussed is CGA; the disease is breast cancer.